Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

• Status: Withdrawn
• Trial end date: 2011-06-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine whether treatment of patients who have toxic epidermal necrolysis with a drug called remicaide increases the number of patients who are alive 30 days laters.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Loyola University
• Treatments: Infliximab

Criteria

Inclusion Criteria:

• Admission to burn unit with a histologic diagnosis of TENs

Exclusion Criteria:

• Pregnancy

• hypersensitivity to remicaide

• history of heart failure

• documented bacteremia

• history of cancer

• inability to consent